View in browser
multispan logo
Eblast 1 November 2023 Title-1

Follow us on Linkedin to receive more updates!

Schedule a Meeting

Assess Target Engagement and Target Pharmacology in

MULTISCREEN™ Non-Radioactive GTP Gi Binding Assays! 

○ 560+ functionally-validated GPCR stable cell lines for

VERSATILITY

 

○ MULTISCREEN™ membrane preparation for

HIGH QUALITY

 

○ Rigorous assay protocols and processes for

ROBUSTNESS AND REPRODUCIBILITY

 

○ An experienced team for

CUSTOMIZATION

Explore More!

Optimized to meet any HTS and lead optimization needs

Flowchart-final-hit-to-lead

MULTISCREEN™  Non-Radioactive

MOR GTP Gi Binding Assay Example

MOR GTP Gi Binding Assay
Learn More

What do our customers say?

“Over the past two years I worked with Multispan on the discovery and optimization of partial agonist ligands for a Gi/o coupled GPCR. Multispan supported the in vitro effort that enabled the compound optimization by implementing and running radiolabel binding assays to evaluate the affinity of ligands, cAMP assays in agonist and antagonist modes to evaluate functional activity, GTPgS assays to accurately measure the efficacy of ligands on the receptor, ARRB-2 assays to evaluate the arresting signaling pathway and receptor internalization assays to evaluate functional activity. The work performed by Multispan was professional with good reproducibility from week-to-week, quick turnaround and cost effective. The Multispan team is easy to work with and when the assays deviated from the norm they were quick to repeat the data and address problems."
 
Julio Medina, Ph.D.
R2M Pharma Inc.
C.E.O.
Screen Shot 2022-07-15 at 6.07.05 pm

 

info@multispaninc.com

 

www.multispaninc.com

Facebook
LinkedIn
X
YouTube

Multispan, Inc., 26219 Eden Landing Road, Hayward, CA 94545, United States, 510-887-0817

Unsubscribe Manage preferences